Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Gossamer Bio, Inc. - Common Stock
(NQ:
GOSS
)
0.3801
-0.0353 (-8.50%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 25, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Gossamer Bio, Inc. - Common Stock
< Previous
1
2
3
4
5
Next >
These stocks are the most active in today's session
↗
Today 14:00 EST
Via
Chartmill
The trading volume of these stocks is deviating from the norm in today's session.
↗
Today 13:00 EST
Via
Chartmill
In today's session, these stocks are experiencing unusual volume.
↗
February 24, 2026
Via
Chartmill
Check out the stocks that are attracting the most attention and driving market activity.
↗
February 23, 2026
Via
Chartmill
Gossamer Bio Stock Plummeted 82% Today — What’s Behind The Crash?
↗
February 23, 2026
Gossamer Bio’s seralutinib did not achieve the predefined statistical bar for its main goal in the phase 3 PROSERA trial.
Via
Stocktwits
Exploring Gossamer Bio's Earnings Expectations
↗
May 14, 2025
Via
Benzinga
HC Wainwright & Co. Maintains Buy Rating for Gossamer Bio: Here's What You Need To Know
↗
January 08, 2024
Via
Benzinga
These stocks are gapping in today's session
↗
February 23, 2026
Via
Chartmill
This Saia Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday
↗
September 10, 2025
Via
Benzinga
Ultragenyx Pharmaceutical, Apple And Other Big Stocks Moving Lower In Monday's Pre-Market Session
↗
July 14, 2025
Via
Benzinga
Presenting on Emerging Growth Conference 82 Day 2 on May 22; Register to live stream
↗
June 13, 2025
Via
Stocktwits
Earnings Scheduled For May 15, 2025
↗
May 15, 2025
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
December 12, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
October 02, 2024
Via
Benzinga
GOSS Stock Earnings: Gossamer Bio Misses EPS, Misses Revenue for Q2 2024
↗
August 12, 2024
GOSS stock results show that Gossamer Bio missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
Via
InvestorPlace
Gossamer Bio's Clean Safety Profile Differentiates It From Merck, Analyst Says
↗
June 25, 2024
Oppenheimer initiated coverage on Gossamer Bio, highlighting seralutinib's clean long-term safety profile for pulmonary arterial hypertension. Seralutinib shows potential in underserved markets.
Via
Benzinga
Gossamer Bio And 2 Other Stocks Under $2 Insiders Are Buying
↗
June 25, 2024
Via
Benzinga
Why Kaival Brands Innovations Shares Are Trading Lower By 47%? Here Are Other Stocks Moving In Friday's Mid-Day Session
↗
June 21, 2024
Via
Benzinga
The Penny Stock Pundits: 3 Companies Poised to Become the Talk of Wall Street
↗
June 13, 2024
Taking a small position in these penny stocks today could have you sitting on a sizable gain by the time Wall Street starts to pile in.
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
June 11, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
↗
May 13, 2024
Via
Benzinga
GOSS Stock Earnings: Gossamer Bio Misses EPS for Q1 2024
↗
May 07, 2024
GOSS stock results show that Gossamer Bio missed analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
Gossamer Bio Collaborates With Italian Drugmaker Chiesi To Advance Lung Health Solutions Worldwide
↗
May 06, 2024
Gossamer Bio partners with Chiesi Farmaceutici to develop and market seralutinib globally, targeting pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
April 25, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
↗
April 05, 2024
Via
Benzinga
Goldman Sachs Maintains Buy Rating for Gossamer Bio: Here's What You Need To Know
↗
March 06, 2024
Via
Benzinga
GOSS Stock Earnings: Gossamer Bio Meets EPS for Q4 2023
↗
March 05, 2024
GOSS stock results show that Gossamer Bio met analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
February 20, 2024
Via
Benzinga
7 Micro-Cap Stocks That Could Majorly Surprise Investors
↗
January 31, 2024
Although extremely small enterprises can be terrifyingly risky, these micro-cap stock surprises deserve a closer look.
Via
InvestorPlace
Why Lantheus Holdings Shares Are Trading Lower By Over 22%? Here Are Other Stocks Moving In Monday's Mid-Day Session
↗
December 18, 2023
Shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) fell sharply during Monday’s session after the company and POINT Biopharma announced topline results from the pivotal phase 3 SPLASH study in metastatic...
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
